WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 652
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 852

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 4'301  4'182  4'064  3'946  3'830  2'709  2'030  1'534 
Births 147  145  142  140  137  104  83  66 
Surviving infants 137  135  133  130  128  96  76  60 
Pop. less than 5 years 655  640  626  612  596  447  353  273 
Pop. less than 15 years 1'725  1'683  1'644  1'604  1'564  1'169  909  696 
Female 15-49 years 1'042  1'013  983  953  924  635  461  346 

Number of reported cases

(Click for retrospective incidence data for Mauritania)
Diphtheria
ChartChart
  18 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  13  14  62  35  1'379  11'441 
Mumps
ChartChart
 
Pertussis
ChartChart
  30  383  7'576 
Polio*
ChartChart
  159 
Rubella
ChartChart
  49  61 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  16 
Tetanus (total)**
ChartChart
  24  12 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Mauritania)
Vaccine year result method % card seen                                                
BCG 2013  97  CES   55  99*  85  98  95  95  48  79 
DTP1 2013  96  CES   55  99*  87  88  95  95 
DTP3 2013  92  CES   55  86  73  84  80  80  31  33 
DTP4         
IPV1          77 
HepB_BD          64  51  49  24 
HepB3 2013  92  CES   55  86  73  84  80  80 
Hib3 2013  92  CES   55  86  73  84  80  80 
JapEnc         
MCV1          83  70  84  80  75  38 
MCV2         
MenA         
PCV1          99  85  88  23 
PCV2          91  77  84 
PCV3          84  71  84  20 
Pol3 2013  91  CES   55  82  67  84  80  80  31  33 
Rota1          95  73 
RotaC          86  56 
RCV1         
TT2plus 2010  41  MICS   32  41  37  42  40  40  15 
PAB         
VAD1         
YFV 1988  36  EPI   69  32 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Mauritania)
BCG
ChartChart
  85  85  98  95  95  78  79 
DTP1
ChartChart
  87  87  88  95  95  73  69 
DTP3
ChartChart
  73  73  84  80  80  51  33 
HepB3
ChartChart
  73  73  84  80  80 
HepB_BD
ChartChart
  51  51 
Hib3
ChartChart
  73  73  84  80  80 
IPV1
  65 
MCV1
ChartChart
  70  70  84  80  75  46  38 
MCV2
 
PCV3
ChartChart
  73  71  71 
Pol3
ChartChart
  67  67  84  80  80  58  33 
RCV1
 
RotaC
ChartChart
  73  56 
YFV
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 55  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 47
From 80 to 89% 20
From 50 to 79% 27
Less than 50% 5
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB birth; Yes
HPV 9-14 years; No From March 2018
IPV 14 weeks; Yes
Measles 9 months; Yes
MR Yes From January 2018
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
Td 1st contact or pregnancy; +1, +6 months;+1, +1 year; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2020  2016-2020  2012-2015  2012-2015  2012-2015  2012-2015  2008-2012 
Nº of districts with microplans that include activities to raise immunization coverage number 55  56  53  53  53  39  39 

System performance

Total Nº districts in country number 55  56  53  53  53  53  53 
Nº districts with DTP3 coverage >=80% number 37  17  30  22  21  15 
% of districts with DTP3 coverage >=80% From 0 to 100% 67  30  57  42  40  28  17 
Nº districts with measles (MCV1) coverage >=95% number 20 
% of districts with MCV1 coverage >=95% From 0 to 100% 36  11  15 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  No  No  No  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  No  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 24  28  41  46  340   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  Yes  Yes  No  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.